Free tool
Stocks far below their 52-week high
We cover 111 companies trading at least 50% below their own 52-week high. The median market value in the group is $285.00M. Across the group, the median move over the past trading day is −0.31%. 9% of the 111 with a 200-day average trade above it. Price change over the past year runs from −69.9% to +47.0% across the middle 80 percent of the group, with a median of −41.1%.
Other lists in this group
Table
111 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| RXST | RxSight, Inc. | $265.36M | Small cap | −25.38% |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% |
| NERV | Minerva Neurosciences, Inc. | $259.27M | Small cap | +129.11% |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% |
| ORGO | Organogenesis Holdings Inc. | $225.18M | Small cap | −63.84% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% |
| NBP | NovaBridge Biosciences | $216.26M | Small cap | −58.44% |
| ZJYL | Jin Medical International Ltd. | $208.31M | Small cap | −82.97% |
| ARMP | Armata Pharmaceuticals, Inc. | $202.64M | Small cap | +123.36% |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% |
| AIRS | AirSculpt Technologies, Inc. | $196.10M | Small cap | −57.30% |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% |
| CNTN | Canton Strategic Holdings, Inc. | $177.69M | Small cap | −55.04% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| WW | WW International, Inc. | $175.98M | Small cap | −45.96% |
| QSI | Quantum-Si incorporated | $173.05M | Small cap | −31.84% |
| MENS | Jyong Biotech Ltd. | $170.30M | Small cap | −95.62% |
| NYXH | Nyxoah SA | $164.12M | Small cap | −73.74% |
| LFMD | LifeMD, Inc. | $156.17M | Small cap | −49.45% |
| TNYA | Tenaya Therapeutics, Inc. | $156.11M | Small cap | −36.71% |
| SPRC | SciSparc Ltd. | $154.36M | Small cap | −82.42% |
| OTLK | Outlook Therapeutics, Inc. | $151.26M | Small cap | −73.76% |
| OWLT | Owlet, Inc. | $150.78M | Small cap | −28.43% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| KRMD | KORU Medical Systems, Inc. | $148.21M | Small cap | −24.47% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% |
| OPRX | OptimizeRx Corporation | $145.98M | Small cap | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $145.90M | Small cap | −82.19% |
| STXS | Stereotaxis, Inc. | $145.29M | Small cap | −49.48% |
| TLSA | Tiziana Life Sciences Ltd | $138.71M | Small cap | −41.08% |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% |
| ADCT | ADC Therapeutics SA | $134.05M | Small cap | −67.39% |
| ENGN | enGene Therapeutics Inc. | $130.63M | Small cap | −55.07% |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% |
| CBUS | Cibus, Inc. | $128.40M | Small cap | +27.27% |
| QTRX | Quanterix Corporation | $126.75M | Small cap | −41.87% |
| GUTS | Fractyl Health, Inc. | $124.77M | Small cap | −25.55% |
| GNLX | Genelux Corporation | $123.52M | Small cap | −25.00% |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% |
| RANI | Rani Therapeutics Holdings, Inc. | $118.23M | Small cap | +49.45% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| NAUT | Nautilus Biotechnology, Inc. | $111.99M | Small cap | +33.34% |
| BNR | Burning Rock Biotech Limited | $110.10M | Small cap | +22.54% |
| BGM | BGM Group Ltd. | $106.17M | Small cap | −96.61% |
| MBOT | Microbot Medical Inc. | $102.09M | Small cap | −62.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.